1-181746010-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001205293.3(CACNA1E):c.3720-4466A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.704 in 152,044 control chromosomes in the GnomAD database, including 37,831 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.70   (  37831   hom.,  cov: 31) 
Consequence
 CACNA1E
NM_001205293.3 intron
NM_001205293.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.420  
Publications
6 publications found 
Genes affected
 CACNA1E  (HGNC:1392):  (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011] 
CACNA1E Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.768  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | ENST00000367573.7 | c.3720-4466A>G | intron_variant | Intron 25 of 47 | 1 | NM_001205293.3 | ENSP00000356545.2 | |||
| CACNA1E | ENST00000360108.7 | c.3663-4466A>G | intron_variant | Intron 24 of 46 | 5 | ENSP00000353222.3 | ||||
| CACNA1E | ENST00000367570.6 | c.3720-4466A>G | intron_variant | Intron 25 of 46 | 1 | ENSP00000356542.1 | ||||
| CACNA1E | ENST00000621791.4 | c.3663-4466A>G | intron_variant | Intron 24 of 45 | 1 | ENSP00000481619.1 | 
Frequencies
GnomAD3 genomes  0.704  AC: 106929AN: 151926Hom.:  37803  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
106929
AN: 
151926
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.704  AC: 107006AN: 152044Hom.:  37831  Cov.: 31 AF XY:  0.708  AC XY: 52608AN XY: 74308 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
107006
AN: 
152044
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
52608
AN XY: 
74308
show subpopulations 
African (AFR) 
 AF: 
AC: 
26484
AN: 
41448
American (AMR) 
 AF: 
AC: 
10112
AN: 
15268
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2636
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
4059
AN: 
5152
South Asian (SAS) 
 AF: 
AC: 
3786
AN: 
4810
European-Finnish (FIN) 
 AF: 
AC: 
7803
AN: 
10596
Middle Eastern (MID) 
 AF: 
AC: 
198
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
49711
AN: 
67980
Other (OTH) 
 AF: 
AC: 
1453
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 1630 
 3260 
 4889 
 6519 
 8149 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 836 
 1672 
 2508 
 3344 
 4180 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2586
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.